← Back to Analyst Consensus 
BILI Buy
Bilibili Inc.
Current Price —
Implied Upside —
Analysts 35
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 12, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Apr 13, 2026 | Morgan Stanley | upgrade | Equal-Weight → Overweight | — | 54% |
| Mar 27, 2026 | Citigroup | upgrade | Neutral → Buy | — | 54% |
| Mar 17, 2026 | JP Morgan | upgrade | Neutral → Overweight | — | 55% |
| Nov 28, 2025 | B of A Securities | maintain | Buy → Buy | $31 | 53% |
| Nov 18, 2025 | JP Morgan | maintain | Neutral → Neutral | $27 | 55% |
| Nov 14, 2025 | Citigroup | maintain | Neutral → Neutral | $27 | 54% |
| Nov 14, 2025 | Benchmark | maintain | Buy → Buy | $29 | 54% |
| Oct 23, 2025 | Bernstein | maintain | Outperform → Outperform | $32 | 52% |
| Oct 14, 2025 | Macquarie | initiate | — → Outperform | $36.03 | 56% |
| Aug 22, 2025 | Barclays | maintain | Overweight → Overweight | $28 | 53% |
| Aug 22, 2025 | Benchmark | maintain | Buy → Buy | $28 | 54% |
| Jul 28, 2025 | JP Morgan | downgrade | Overweight → Neutral | $24 | 55% |
| Jul 17, 2025 | B of A Securities | maintain | Buy → Buy | $27 | 53% |
| Jul 8, 2025 | Bernstein | initiate | — → Outperform | $28 | 52% |
| May 21, 2025 | HSBC | upgrade | Hold → Buy | $22.5 | 52% |
| Feb 21, 2025 | Benchmark | maintain | Buy → Buy | $30 | 54% |
| Feb 21, 2025 | Barclays | maintain | Overweight → Overweight | $25 | 53% |
| Nov 18, 2024 | Barclays | maintain | Overweight → Overweight | $24 | 53% |
| Nov 15, 2024 | Benchmark | maintain | Buy → Buy | $24 | 54% |
| Nov 12, 2024 | Mizuho | maintain | Outperform → Outperform | $21 | 52% |
| Oct 25, 2024 | B of A Securities | maintain | Buy → Buy | $22.5 | 53% |
| Sep 3, 2024 | B of A Securities | maintain | Buy → Buy | $19 | 53% |
| Aug 23, 2024 | Bernstein | maintain | Market Perform → Market Perform | $13 | 52% |
| Aug 23, 2024 | Barclays | upgrade | Equal-Weight → Overweight | $19 | 53% |
| Aug 22, 2024 | Nomura | upgrade | Neutral → Buy | $18 | — |
| Jun 18, 2024 | JP Morgan | upgrade | Neutral → Overweight | $21 | 55% |
| May 31, 2024 | UBS | upgrade | Neutral → Buy | $18 | 54% |
| May 24, 2024 | Benchmark | maintain | Buy → Buy | $16 | 54% |
| May 24, 2024 | Barclays | upgrade | Underweight → Equal-Weight | $14 | 53% |
| May 10, 2024 | CLSA | upgrade | Outperform → Buy | $16.8 | 54% |
| May 10, 2024 | Mizuho | maintain | Buy → Buy | $17 | 52% |
| Mar 11, 2024 | Citigroup | downgrade | Buy → Neutral | $12.5 | 54% |
| Mar 11, 2024 | JP Morgan | upgrade | Underweight → Neutral | $11 | 55% |
| Mar 8, 2024 | Benchmark | maintain | Buy → Buy | $15 | 54% |
| Mar 8, 2024 | Mizuho | maintain | Buy → Buy | $15 | 52% |
| Jan 17, 2024 | Mizuho | maintain | Buy → Buy | $16 | 52% |
| Dec 4, 2023 | UBS | downgrade | Buy → Neutral | $13.2 | 54% |
| Nov 30, 2023 | Benchmark | maintain | Buy → Buy | $21 | 54% |
| Nov 30, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $15.6 | 54% |
| Nov 30, 2023 | Barclays | downgrade | Equal-Weight → Underweight | $10 | 53% |
| Oct 12, 2023 | Goldman Sachs | maintain | Neutral → Neutral | $17.4 | 54% |
| Aug 21, 2023 | Barclays | maintain | Equal-Weight → Equal-Weight | $15 | 53% |
| Aug 18, 2023 | UBS | maintain | Buy → Buy | $22 | 54% |
| Aug 18, 2023 | Benchmark | reiterate | Buy → Buy | $35 | 54% |
| Aug 18, 2023 | Baird | maintain | Neutral → Neutral | $120 | 55% |
| Jul 27, 2023 | JP Morgan | downgrade | Overweight → Equal-Weight | $13 | 55% |
| Jul 25, 2023 | HSBC | maintain | Hold → Hold | $16 | 52% |
| Jun 8, 2023 | UBS | maintain | Buy → Buy | $23 | 54% |
| Jun 5, 2023 | Benchmark | reiterate | Buy → Buy | $35 | 54% |
Price Target Trend
May 25, 2026 Oct 27, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days